Santhera Pharmaceuticals (Switzerland) Price on December 12, 2024
| SANN Stock | CHF 9.25 0.33 3.44% |
If you're considering investing in Santhera Stock, it is important to understand the factors that can impact its price. As of today, the current price of Santhera Pharmaceuticals stands at 9.25, as last reported on the 14th of December 2024, with the highest price reaching 9.58 and the lowest price hitting 9.20 during the day. At this stage we consider Santhera Stock to be somewhat reliable. Santhera Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0077, which indicates the firm had a 0.0077% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Santhera Pharmaceuticals Holding, which you can use to evaluate the volatility of the company. Please validate Santhera Pharmaceuticals' Coefficient Of Variation of 5155.52, semi deviation of 2.14, and Risk Adjusted Performance of 0.0212 to confirm if the risk estimate we provide is consistent with the expected return of 0.0197%.
Santhera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Santhera |
Sharpe Ratio = 0.0077
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SANN |
Estimated Market Risk
| 2.55 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Santhera Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Santhera Pharmaceuticals by adding Santhera Pharmaceuticals to a well-diversified portfolio.
Santhera Pharmaceuticals Valuation on December 12, 2024
It is possible to determine the worth of Santhera Pharmaceuticals on a given historical date. On December 12, 2024 Santhera was worth 9.97 at the beginning of the trading date compared to the closed value of 9.58. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Santhera Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Santhera Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Santhera Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Santhera Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 9.75 | 9.90 | 9.50 | 9.89 | 142,899 | |
12/12/2024 | 9.97 | 9.97 | 9.15 | 9.58 | 26,533 |
| 9.58 | 9.58 | 9.20 | 9.25 | 25,575 |
| Backtest Santhera Pharmaceuticals | | | Santhera Pharmaceuticals History | | | Santhera Pharmaceuticals Valuation | Previous | Next |
Santhera Pharmaceuticals Trading Date Momentum on December 12, 2024
| On December 13 2024 Santhera Pharmaceuticals Holding was traded for 9.25 at the closing time. The highest price during the trading period was 9.58 and the lowest recorded bid was listed for 9.20 . The volume for the day was 25.6 K. This history from December 13, 2024 contributed to the next trading day price decline. The trading price change to the next closing price was 3.44% . The trading price change to the current price is 0.00% . |
Santhera Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Santhera Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Santhera Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Santhera financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Santhera Pharmaceuticals Stock history
Santhera Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Santhera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Santhera Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Santhera Pharmaceuticals stock prices may prove useful in developing a viable investing in Santhera Pharmaceuticals
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for orphan and other diseases with high unmet medical needs in the European countries. Santhera Pharmaceuticals Holding AG is headquartered in Pratteln, Switzerland. SANTHERA N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 114 people.
Santhera Pharmaceuticals Stock Technical Analysis
Santhera Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Santhera Pharmaceuticals Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Santhera Pharmaceuticals Holding cannot be verified against its exchange. Please verify the symbol is currently traded on SIX Swiss Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Santhera Pharmaceuticals December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Santhera Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Santhera Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Santhera Pharmaceuticals stock market strength indicators, traders can identify Santhera Pharmaceuticals Holding entry and exit signals to maximize returns
Santhera Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Santhera Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Santhera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Santhera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0212 | |||
| Jensen Alpha | 0.0235 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.2243 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Santhera Stock Analysis
When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.